Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

Chris Lange | Mar 18, 2015 at 2:10 PM EDT

How the Weaker Euro Is Impacting Biotech Earnings

Wells Fargo released a report Wednesday that considers the future of major biotech companies in relation to the weak euro.

Lee Jackson | Mar 16, 2015 at 8:15 AM EDT

3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week

One thing that can always drive a biotech stock higher is positive clinical data, and this week some big-time biotech…

Chris Lange | Mar 11, 2015 at 9:15 AM EDT

Short Sellers Get More Aggressive on Big Biotech

24/7 Wall St. has reviewed the top biotech companies, and the February 27 short interest data have been compared with…

Jon C. Ogg | Mar 6, 2015 at 7:15 AM EST

9 Well-Established Companies That Just Refuse to Pay Dividends

24/7 Wall St. has identified nine solid companies that are on very stable ground but that just refuse to pay…

Lee Jackson | Mar 4, 2015 at 8:35 AM EST

The 5 Most Loved Biotech Stocks of Portfolio Managers

A big part of the Nasdaq is biotech, and a new report from Cowen details the stocks that big money…

Chris Lange | Feb 26, 2015 at 9:25 AM EST

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

The short interest data are out for the February 13 settlement date. 24/7 Wall St. has reviewed the top biotech…

Jon C. Ogg | Feb 23, 2015 at 2:05 PM EST

The Most Dominant Stocks in 2015 Taking Nasdaq to 5,000 and Beyond

24/7 Wall St. wanted to find out which of the major Nasdaq stocks would lead the index back over 5,000…

Lee Jackson | Feb 18, 2015 at 8:25 AM EST

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Here are the four top biotech stocks to buy now according to Deutsche Bank. These leaders have established drugs, solid…

Chris Lange | Feb 11, 2015 at 9:40 AM EST

Short Sellers Look Scared of Big Biotech

The short interest data are out for the January 30 settlement date. 24/7 Wall St. has reviewed the top biotech…

Chris Lange | Jan 30, 2015 at 10:35 AM EST

Did Biogen Run Too Much After Earnings?

Biogen Idec shares hit a new multiyear high Friday morning following the better-than-expected fourth-quarter earnings.

Chris Lange | Jan 28, 2015 at 11:00 AM EST

Short Sellers Starting to Gang Up on Biotech

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. For the majority of the selected…

Chris Lange | Jan 13, 2015 at 8:55 AM EST

Short Interest in Biotechs Signals Optimism

24/7 Wall St. has reviewed the short interest in the top biotech companies, without focusing on speculative companies.

Chris Lange | Jan 7, 2015 at 2:51 PM EST

Wells Fargo’s Top Biotech Stocks for 2015

ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech…

Lee Jackson | Jan 7, 2015 at 10:35 AM EST

Analyst’s 8 Top Health Care Stocks for 2015

A new research report from the analysts at Cowen highlights the firm's top health care picks, many of which have…

Jon C. Ogg | Jan 6, 2015 at 8:30 AM EST

Top Analyst Upgrades and Downgrades: GE, Gilead, Oracle, Under Armour, El Pollo Loco and More

Tuesday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include GE, Gilead Sciences, Oracle, Under Armour…

1 … 24 25 26 27 28 … 41

Biogen : BIIB

All Biogen Articles

How the Weaker Euro Is Impacting Biotech Earnings

3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week

Short Sellers Get More Aggressive on Big Biotech

9 Well-Established Companies That Just Refuse to Pay Dividends

The 5 Most Loved Biotech Stocks of Portfolio Managers

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

The Most Dominant Stocks in 2015 Taking Nasdaq to 5,000 and Beyond

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Short Sellers Look Scared of Big Biotech

Did Biogen Run Too Much After Earnings?

Short Sellers Starting to Gang Up on Biotech

Short Interest in Biotechs Signals Optimism

Wells Fargo’s Top Biotech Stocks for 2015

Analyst’s 8 Top Health Care Stocks for 2015

Top Analyst Upgrades and Downgrades: GE, Gilead, Oracle, Under Armour, El Pollo Loco and More

Gambling Creator Bluffin Bob Rejected a $30M+ Casino Deal and Never Looked Back

The Market Is Panicking on Broadcom. This Is Why I Keep Buying The Stock

Experts Warn: Companies Cutting Headcount to Boost Efficiency May Be Betting on the Wrong Future

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)

Medicare's Hospital Fund Now Runs Short in Early 2033 — a Quarter Sooner Than Last Year's Warning

Gambling Creator Bluffin Bob Rejected a $30M+ Casino Deal and Never Looked Back

The Market Is Panicking on Broadcom. This Is Why I Keep Buying The Stock

Biogen : BIIB

All Biogen Articles

How the Weaker Euro Is Impacting Biotech Earnings

3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week

Short Sellers Get More Aggressive on Big Biotech

9 Well-Established Companies That Just Refuse to Pay Dividends

The 5 Most Loved Biotech Stocks of Portfolio Managers

Short Sellers Increase Bets Against Biotech as Shares Continue to Rise

The Most Dominant Stocks in 2015 Taking Nasdaq to 5,000 and Beyond

Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015

Short Sellers Look Scared of Big Biotech

Did Biogen Run Too Much After Earnings?

Short Sellers Starting to Gang Up on Biotech

Short Interest in Biotechs Signals Optimism

Wells Fargo’s Top Biotech Stocks for 2015

Analyst’s 8 Top Health Care Stocks for 2015

Top Analyst Upgrades and Downgrades: GE, Gilead, Oracle, Under Armour, El Pollo Loco and More

Gambling Creator Bluffin Bob Rejected a $30M+ Casino Deal and Never Looked Back

The Market Is Panicking on Broadcom. This Is Why I Keep Buying The Stock

Experts Warn: Companies Cutting Headcount to Boost Efficiency May Be Betting on the Wrong Future

Featured Reads

The IRS Loophole That Lets You Give Your Kids Unlimited Money Tax-Free (It's Not the $19,000 Gift Limit)

Medicare's Hospital Fund Now Runs Short in Early 2033 — a Quarter Sooner Than Last Year's Warning